Dr Hanjing Xie, MD, Associate Prof.
Chief Medical Officer
Hanjing joined AMAL Therapeutics in 2023 as Chief Medical Officer.
Hanjing Xie is a medical doctor, associate professor, and senior physician in oncology. She holds a PhD in clinical pharmacology and is triple board certified in clinical oncology, internal medicine, and hematology. She has over 25 years of clinical experience mostly from Karolinska University Hospital. Hanjing has been active in pharmaceutical industry since 2015 and has held several senior leading positions including role of Chief Medical Officer for three Swedish biotech companies most recently.